Vaxcyte

PCVX · NASDAQ

$66.23+$2.55 (+4.00%)TodayMarket closed · Oct 20, 4:05 PM ET

Prev close $63.68

Latest news

NewsOct 12, 5:12 AM ETAnanya Gairola
Stephen King Slams Trump’s New Press Secretary as Past Vaccine Conspiracy Theories, Third-Term Posts Spark Fresh Controversy: 'She Appears to Have Tried to…'
NewsOct 9, 3:11 PM ETNeeraj Jain
A New War on Cancer? NIH's Vaccine Initiative Sparks Biotech Stock Rally
NewsOct 8, 5:59 AM ET
'Russia Denies Report of Second Case of Illness in Siberia' - Bloomberg
NewsOct 6, 12:04 PM ETAvi Kapoor
Crude Oil Edges Lower; Lamb Weston Shares Surge Following Upbeat Q1 Earnings
NewsOct 6, 8:28 AM ETRishabh Mishra
Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Gain as Scott Bessent Doubles Down on Iran Pressure— OPCH, PCVX, STZ in Focus (UPDATED)
NewsOct 6, 12:27 AM ETMohd Haider
Moderna, Vaxcyte and Novavax Are Trending After-Hours as Suspected Pneumonic Plague In Russia Stirs Anxiety
NewsOct 5, 12:43 PM ETAvi Kapoor
Dow Gains 100 Points; ISM Services PMI Falls In September
Press releaseOct 5, 9:51 AM ETGlobe Newswire
Biotech Brainiacs and Breakthroughs
NewsOct 5, 8:55 AM ETVandana Singh
Vaxcyte Stock Hits New 52-Week High - Here’s Why
Press releaseOct 5, 6:00 AM ETGlobe Newswire
Vaxcyte Reports Positive Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate Vaccine Candidate
Press releaseSep 3, 4:05 PM ETGlobe Newswire
Vaxcyte Appoints Chief Medical Officer and Chief Legal Officer; Narrows Guidance for Expected VAX-31 OPUS-1 Topline Data
NewsAug 18, 11:52 AM ETChris Katje
Warren Buffett Disciple Seth Klarman Bets on Cruise Lines, Auto Parts, Amazon and Bill Ackman in Q2
Press releaseAug 5, 4:05 PM ETGlobe Newswire
Vaxcyte Reports Second Quarter 2026 Financial Results and Provides Business Update
NewsJun 29, 1:35 PM ET
10 Health Care Stocks With Whale Alerts In Today’s Session
Press releaseJun 2, 4:05 PM ETGlobe Newswire
Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults
NewsMay 6, 5:03 PM ET
Earnings Scheduled For May 6, 2026
Press releaseMay 6, 4:05 PM ETGlobe Newswire
Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update
Press releaseMar 25, 7:30 AM ETGlobe Newswire
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer
Press releaseMar 23, 8:30 AM ETGlobe Newswire
Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
Press releaseMar 18, 7:34 PM ETGlobe Newswire
Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte's 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate
Press releaseFeb 24, 4:05 PM ETGlobe Newswire
Vaxcyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
NewsFeb 24, 6:11 AM ET
Earnings Scheduled For February 24, 2026
NewsFeb 23, 11:01 AM ET
Earnings Outlook For Vaxcyte
NewsDec 1, 8:43 AM ETAvi Kapoor
CleanSpark, Cipher Mining, Bitdeer Technologies And Other Big Stocks Moving Lower In Monday's Pre-Market Session
NewsSep 30, 11:42 AM ETVandana Singh
Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown
Press releaseSep 30, 8:05 AM ETBusiness Wire
Tentarix Biotherapeutics Strengthens Executive Team
NewsSep 11, 10:23 AM ETVandana Singh
Merck Advances Childhood Pneumococcal Care With Promising Vaccine Data
NewsAug 7, 8:14 AM ETAvi Kapoor
Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
NewsMay 20, 11:20 AM ET
'US FDA Advisers To Consider If New COVID Shots Should Target LP.8.1 Subvariant' - Reuters News
NewsMar 31, 1:05 PM ET
12 Health Care Stocks Moving In Monday's Intraday Session
NewsMar 31, 8:05 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsFeb 25, 3:32 AM ET
Earnings Scheduled For February 25, 2025
Press releaseJan 7, 1:13 AM ETPRNewswire
Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm
NewsNov 17, 9:20 AM ETLekha Gupta
Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
Press releaseNov 5, 4:01 PM ETGlobe Newswire
Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update
NewsSep 3, 9:40 AM ETVandana Singh
Bacterial Infections Vaccine Developer Vaxcyte's Pneumococcal Shot Shows Promise in Mid-Stage Trial, Stock Shoots Higher
NewsSep 3, 8:27 AM ET
Market-Moving News for September 3rd
Press releaseAug 26, 1:30 PM ETPRNewswire
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vaxcyte, Inc. (NASDAQ: PCVX)

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Stephen King Slams Trump’s New Press Secretary as Past Vaccine Conspiracy Theories, Third-Term Posts Spark Fresh Controversy: 'She Appears to Have Tried to…'

A New War on Cancer? NIH's Vaccine Initiative Sparks Biotech Stock Rally

'Russia Denies Report of Second Case of Illness in Siberia' - Bloomberg

Crude Oil Edges Lower; Lamb Weston Shares Surge Following Upbeat Q1 Earnings

Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Gain as Scott Bessent Doubles Down on Iran Pressure— OPCH, PCVX, STZ in Focus (UPDATED)

Moderna, Vaxcyte and Novavax Are Trending After-Hours as Suspected Pneumonic Plague In Russia Stirs Anxiety

Dow Gains 100 Points; ISM Services PMI Falls In September

Biotech Brainiacs and Breakthroughs

Vaxcyte Stock Hits New 52-Week High - Here’s Why

Vaxcyte Reports Positive Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate Vaccine Candidate

Vaxcyte Appoints Chief Medical Officer and Chief Legal Officer; Narrows Guidance for Expected VAX-31 OPUS-1 Topline Data

Warren Buffett Disciple Seth Klarman Bets on Cruise Lines, Auto Parts, Amazon and Bill Ackman in Q2

Vaxcyte Reports Second Quarter 2026 Financial Results and Provides Business Update

10 Health Care Stocks With Whale Alerts In Today’s Session

Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults

Earnings Scheduled For May 6, 2026

Vaxcyte Reports First Quarter 2026 Financial Results and Provides Business Update

Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer

Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults

Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte's 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate

Vaxcyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Earnings Scheduled For February 24, 2026

Earnings Outlook For Vaxcyte

CleanSpark, Cipher Mining, Bitdeer Technologies And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Thermo Fisher Launches Four-Part Bond Offering Ahead Of Possible Government Shutdown

Tentarix Biotherapeutics Strengthens Executive Team

Merck Advances Childhood Pneumococcal Care With Promising Vaccine Data

Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

'US FDA Advisers To Consider If New COVID Shots Should Target LP.8.1 Subvariant' - Reuters News

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Monday's Pre-Market Session

Earnings Scheduled For February 25, 2025

Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm

Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers

Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update

Bacterial Infections Vaccine Developer Vaxcyte's Pneumococcal Shot Shows Promise in Mid-Stage Trial, Stock Shoots Higher

Market-Moving News for September 3rd

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vaxcyte, Inc. (NASDAQ: PCVX)